U.S. stock market midday update: Radiopharm Theranostics down 14.48%, clinical benefits unable to mask losses and valuation risksPrice Alert·16 hours agoRADX-9.56%
Radiopharm Theranostics Secures Multimillion-Dollar Financings to Advance Oncology Radiopharmaceutical PipelineTip Ranks·16 hours agoRADX-9.56%
Radiopharm Theranostics announces extraordinary general meeting for shareholder approvalsPUBT·17 hours agoRADX-9.56%
U.S. stock night market opening fluctuations: Radiopharm Theranostics fell 7.65% in the night market; Cadence Design rose 3.50% in the night marketPrice Alert·1 day ago, 07:12 PMRADX-9.56%CDNS+1.80%
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga_article·1 day ago, 04:06 PMRDHL+4.29%OPK+33.06%
Radiopharm Theranostics prices unregistered warrants in private placement at US$3.79 per ADSPUBT·1 day ago, 05:07 AMRADX-9.56%
Inside US Niche Markets: TAL's Earnings and a Flurry of Micro-Cap Capital RaisesGlobal Report·Jul 26 at 04:18 AMTPET-0.26%TAL-1.14%
Tech and Biotech Overhauls Accelerate Amid 50% Revenue SurgesGlobal Report·Jul 26 at 04:15 AMTKR-0.84%RADX-9.56%
The Value Chain Beyond Aggregators: Unpacking the Hidden Plumbers of the U.S. MarketGlobal Report·Jul 25 at 04:13 AMEA-0.10%TTDKY-0.55%
US Stocks Mixed; American Express Shares Fall Following Q2 Resultsbenzinga_article·Jul 24 at 08:45 AMAXP+0.37%RADX-9.56%
Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan | RADX Stock NewsStockTitan·Jul 23 at 10:15 PMRADX-9.56%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Jul 24 at 07:05 AMZVRA+0.21%RADX-9.56%
